合成MRI T1/T2值融入双参数VI-RADS预测肌层浸润性膀胱癌的价值
该前瞻性双中心研究纳入42例经病理证实的尿路上皮癌患者,评估合成MRI(SyMRI)T1、T2值对肌层浸润性膀胱癌(MIBC)的诊断价值。结果显示MIBC的T1、T2值显著低于非肌层浸润性膀胱癌,将T2值整合入双参数VI-RADS后AUC从0.881显著提升至0.994(P=0.021),T1值整合后提升不显著。
要点
- MIBC病灶SyMRI T1、T2值显著低于NMIBC,T2值≤115 ms提示肌层浸润可能。
- bpVI-RADS+T2在评分≥4时AUC达0.994,明显优于单独bpVI-RADS的0.881。
- 日常阅片可结合SyMRI T2值辅助bpVI-RADS评分,尤其对边界病例有增量价值。
核心结论
- SyMRI衍生的T1和T2值有助于区分膀胱癌肌层浸润,MIBC病灶的T1、T2值显著低于NMIBC。
- 将T2值整合入bpVI-RADS框架可显著提升预测MIBC的诊断效能(AUC 0.994 vs 0.881,P=0.021)。
- bpVI-RADS+T1较单独bpVI-RADS诊断效能仅轻微改善,差异无统计学意义(AUC 0.913 vs 0.881,P=0.605)。
研究设计与样本
- 前瞻性双中心研究,纳入42例经病理证实的尿路上皮癌患者(平均年龄71.90±9.70岁,90.5%男性,23.8%为MIBC)。
- 所有患者接受膀胱MRI检查,由两名放射科医师独立基于T2加权和扩散加权图像进行bpVI-RADS评分,意见分歧经资深放射科医师协商达成共识。
- 在SyMRI衍生图上手动勾画肿瘤体积,提取T1和T2定量值,通过ROC曲线分析确定区分MIBC与NMIBC的最佳截断值。
关键影像表现/征象
- MIBC病灶在SyMRI定量图中表现为T1值、T2值均显著低于NMIBC病灶。
- 区分MIBC与NMIBC的SyMRI最佳截断值为T1值1370 ms、T2值115 ms。
诊断标准与关键数值
- SyMRI T1值区分MIBC与NMIBC的最佳截断值为1370 ms,T2值最佳截断值为115 ms。
- bpVI-RADS单独使用时,以评分≥4为截断值,AUC为0.881。
- bpVI-RADS+T2模型在评分≥4的截断值下AUC为0.994,与单独bpVI-RADS比较差异有统计学意义(P=0.021)。
- bpVI-RADS+T1模型AUC为0.913,与单独bpVI-RADS比较差异无统计学意义(P=0.605)。
临床应用与阅片要点
- 对bpVI-RADS评分为3分的边界病例,可参考SyMRI T2值进行评分调整,T2值≤115 ms倾向于升级,高于115 ms倾向于降级。
- 报告时可补充记录病灶的SyMRI T1值和T2值,为临床判断肌层浸润提供定量参考。
- SyMRI定量图需手动勾画肿瘤体积后提取数值,操作时应注意避开液化坏死及钙化区域以保证测量准确性。
局限性
- 本研究为前瞻性设计但样本来自两个中心,未描述外部验证集,截断值的普适性尚需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the diagnostic value of synthetic MRI (SyMRI)-derived T1 and T2 values in predicting muscle-invasive bladder cancer (MIBC), and assess the feasibility of integrating them into the biparametric MRI Vesical Imaging-Reporting and Data System (bpVI-RADS).
METHODS: This prospective dual-center study included 42 patients (mean age: 71.90 ± 9.70 years, 90.5% male, 23.8% MIBC) with histologically confirmed urothelial carcinoma who underwent bladder MRI. Two radiologists independently assigned bpVI-RADS scores based on T2-weighted and diffusion-weighted images, blinded to pathological, with consensus reached through consultation with a senior radiologist. Tumor volumes were manually delineated on SyMRI-derived maps to extract T1 and T2 values. Two modified models (bpVI-RADS + T1 and bpVI-RADS + T2) were created by adjusting bpVI-RADS scores according to optimal T1 or T2 cutoff values determined via receiver operating characteristic (ROC) curve analysis. Diagnostic performance was assessed with ROC analysis, and AUCs were compared using the DeLong test.
RESULTS: MIBC lesions showed significantly lower T1 and T2 values than non-muscle-invasive bladder cancer (NMIBC). Optimal cutoff values for T1 and T2 to differentiate MIBC from NMIBC were 1370 msec and 115 msec, respectively. The bpVI-RADS + T2 achieved significantly higher AUC (0.994 vs. 0.881, P = 0.021) than bpVI-RADS at a cutoff score of ≥ 4. The bpVI-RADS + T1 showed slightly improved diagnostic performance than bpVI-RADS (0.913 vs. 0.881, P = 0.605).
CONCLUSION: SyMRI-derived T1 and T2 values could help distinguish muscle invasion in bladder cancer. Incorporating T2 values into the bpVI-RADS framework significantly enhances diagnostic performance for predicting MIBC.
引用
- Zhao, Zhao, Bu, et al. Added value of synthetic MRI in refining biparametric MRI VI-RADS for predicting muscle-invasive bladder cancer. Abdom Radiol (NY). 2026. PMID: 41553526. doi:10.1007/s00261-025-05365-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。